MaxHealthcare holding managed by GIC rises to 5.005% stake
Key highlights
- GIC-managed accounts bought 304,579 MaxHealthcare shares through the open market on 18 November 2026.
- The combined MaxHealthcare voting-capital holding rose from 4.974% to 5.005%.
- The Government of Singapore held 37,684,370 MaxHealthcare shares after the acquisition.
- The Monetary Authority of Singapore held 11,033,674 MaxHealthcare shares after the acquisition.
powered by IRIS

MaxHealthcare Institute Limited’s GIC-managed holding rose to 5.005% of voting capital on 18 November 2026 after an open-market purchase of 304,579 equity shares. The stake managed for the Government of Singapore and the Monetary Authority of Singapore increased from 48,413,465 shares, or 4.974%, to 48,718,044 shares.
Know Max Healthcare Institute inside out
Results, valuation, peers and who's buying, in one view.
How did GIC-managed holdings cross 5% in MaxHealthcare?
GIC Private Limited, acting as investment manager for the Government of Singapore and the Monetary Authority of Singapore, acquired 304,579 MaxHealthcare equity shares through the open market on 18 November 2026. The disclosure was made under Regulation 29(1) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, known as the SAST Regulations.
The purchase lifted the combined holding from 4.974% to 5.005% of MaxHealthcare’s total share or voting capital, a rise of 0.031 percentage points. On a total diluted share or voting-capital basis, the holding moved from 4.932% to 4.963%, reflecting the larger assumed share base used for that calculation.
GIC has the power to exercise voting rights for all shares it manages for the two Singapore entities, according to the filing. The filing also identifies GIC as not belonging to MaxHealthcare’s promoter or promoter group and lists the National Stock Exchange of India Limited and BSE Limited as the company’s listing venues.
How was the MaxHealthcare purchase divided between the two entities?
The Government of Singapore acquired 257,834 of the 304,579 MaxHealthcare shares, while the Monetary Authority of Singapore acquired 46,745 shares on 18 November 2026. Their holdings remained separately reported even though GIC manages the combined 48,718,044 shares and exercises voting rights over them.
The Government of Singapore’s voting-capital interest increased from 3.845% to 3.872%, while the Monetary Authority of Singapore’s increased from 1.129% to 1.134%. The respective changes of 0.026 percentage points and 0.005 percentage points equal the reported combined increase of 0.031 percentage points.
On the diluted basis, the Government of Singapore held 3.839% after the transaction, compared with 3.813% before it. The Monetary Authority of Singapore held 1.124%, compared with 1.119%, and the combined diluted holding was 4.963% after the acquisition.
Got a follow-up? Ask IRIS
What share-capital base was used for the MaxHealthcare calculation?
MaxHealthcare’s disclosure refers to 973,310,251 equity shares in the shareholding pattern as of 30 September 2026. It also notes that paid-up equity share capital increased to 973,327,054 shares on 30 October 2026 after an allotment under the Employee Stock Option Scheme 2022.
For the Regulation 29(1) disclosure, the filing says it used the latest publicly available equity-share-capital and voting-capital figures. Against that base, the 48,718,044 shares held after the transaction represented 5.005% of voting capital, compared with 4.974% for the 48,413,465 shares held before it.
The filing separately gives total diluted share or voting capital of 981,543,023 equity shares after the acquisition, based on the shareholding pattern as of 30 September 2026. It defines diluted share or voting capital as the total number of shares assuming full conversion of outstanding convertible securities or warrants into equity shares.
What securities and transaction terms did the filing report?
The acquired securities were equity shares carrying voting rights, and the filing identifies the mode as an open-market acquisition on 18 November 2026. It does not state a per-share purchase price, total consideration, investment objective or a plan for further MaxHealthcare purchases or sales.
The filing reports nil voting rights held other than through equity shares, nil warrants or convertible securities, and nil encumbrances. The nil encumbrance disclosure covers pledges, liens, non-disposal undertakings and other encumbrances for the 48,718,044 shares reported after the acquisition.
The 5.005% voting-capital measure is therefore based on ordinary equity shares rather than on instruments that may convert into shares later. The lower 4.963% diluted measure results from applying the 48,718,044 shares to the disclosed diluted capital of 981,543,023 shares.
Conclusion
The 18 November 2026 transaction moved the GIC-managed MaxHealthcare holding above 5% of reported voting capital through the acquisition of 304,579 shares. The Government of Singapore accounted for 257,834 shares of the purchase and the Monetary Authority of Singapore for 46,745 shares, taking their combined holding to 48,718,044 shares.
The next disclosed matter to watch is any further change in MaxHealthcare’s share count following the 30 October 2026 allotment under the Employee Stock Option Scheme 2022, which raised paid-up capital to 973,327,054 shares. Further open-market purchases or sales by the GIC-managed accounts would also determine whether the reported 5.005% holding moves further from the 5% level.


